BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 5, 2007
View Archived Issues
Novel candidate gene for Parkinson's disease identified
Read More
Treatment option for opioid dependency imparted in recent Reckitt Benckiser patent
Read More
New coagulation factor VIIa inhibitors disclosed in recent Eisai patent
Read More
Recent GSK and Mochida patents report novel analgesic agents
Read More
Studies detail efficacy of sugammadex in reversing neuromuscular blockade
Read More
DTS-201 safe in first-in-man study
Read More
In vivo antinociceptive effects reported for novel alpha2-adrenoceptor agonist
Read More
New gene associated with cardiovascular disease identified
Read More
Novel compounds overcome drug resistance in tumors expressing BCRP
Read More
Preclinical and clinical profile of BIIB-021, an Hsp90 inhibitor with antitumor activity
Read More
Antitumor effects seen with JX-594 in patients with liver tumors
Read More
MGCD-0103 and gemcitabine given in combination to patients with solid tumors
Read More
Santhera reports positive results from phase IIa trial of SNT-MC17
Read More
Ono and Medarex file IND for MDX-1106/ONO-4538 for hepatitis C
Read More
Eisai delays filing of regulatory submission of E-2007 until the fourth quarter of 2008
Read More
Cytokine reports oral efficacy of anti-cytokine semapimod
Read More
Taisho and Pfizer sign letter of intent for schizophrenia drug candidate
Read More
Tranzyme initiates phase IIb TZP-101 trial for severe gastroparesis
Read More
Lev amends Cinryze BLA for the treatment of hereditary angioedema
Read More
Vanda presents top-line results of phase II trial of VSF-173 for excessive sleepiness
Read More
Clinuvel initiates phase II trials of CUV-1647 for sun damage and actinic keratosis
Read More
Addrenex and Sciele initiate phase III trials for Clonicel
Read More
Enzon initiates phase I study of EZN-2968 to evaluate additional dosing schedule
Read More
Neoprobe and FDA agree on design of phase III trials for Lymphoseek
Read More
BioLineRx presents positive results from phase IIa interim trial of BL-1020 for schizophrenia
Read More
FDA accepts Indevus Pharmaceuticals' NDA for Nebido for male hypogonadism
Read More
FDA issues a not approvable letter for gepirone extended-release tablets
Read More
Trophos reports clinical results for TRO-19622 in patients with ALS
Read More
First U.S. clinical results for Avigen's antispastic agent AV-650
Read More
Noninvasive NGF-based therapies for Alzheimer's disease described by Italian investigators
Read More